---  
layout: startup_page  
title: "Alesta Therapeutics"  
id: "alestatherapeutics.com"  
permalink: "/alestatherapeuticsalestatherapeutics.com01082025/"  
website: "https://alestatherapeutics.com/"  
funding_round: "Series A"  
funding_amount: "€65M"  
investors: "Frazier Life Sciences, Droia Ventures, Novartis Venture Fund, RTW Investments, RV Invest, Thuja Capital, SSI Strategy"  
about: "Alesta Therapeutics is a biotechnology company developing novel oral small molecule therapies for rare diseases. Their lead asset, ALE1, targets hypophosphatasia, while ALE2 addresses Charcot-Marie-Tooth disease. The company aims to provide transformative treatments for patients with significant unmet needs in these areas."  
markets: "Biotechnology, Rare Diseases"  
hq: "Leiden, South Holland, Netherlands"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/alestatx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: ""  
pitchbook: "https://pitchbook.com/profiles/company/495396-55"  

date_display: "08-Jan-2025"  
date: "2025-01-08"

# SEO Optimization  
meta_title: "Alesta Therapeutics - Series A Funding (€65M)"  
meta_description: "Alesta Therapeutics, Alesta Therapeutics is a biotechnology company developing novel oral small molecule therapies for rare diseases. Their lead asset, ALE1, targets hypop..."  
meta_keywords: "Alesta Therapeutics, Biotechnology, Rare Diseases, Series A funding"  
canonical_url: "https://startup.projectstartups.com/alestatherapeuticsalestatherapeutics.com01082025/"  
---